Table 1.
Rosuvastatin (n = 232) | Atorvastatin (n = 233) | |
Gender, male/female (%) | 128/104 (55.2/44.8) | 136/97 (58.4/41.6) |
Race, white (%) | 229 (98.7) | 229 (98.3) |
Mean age, years (SD) | 63.5 (8.8) | 65.0 (8.6) |
Mean weight, kg (SD) | 84.8 (14.3) | 82.5 (13.5) |
Mean BMI, kg/m2 (SD) | 29.0 (3.6) | 28.4 (3.6) |
Mean baseline LDL-C, mmol/L (SD) | 4.6 (0.85) | 4.6 (0.82)a |
Mean baseline HDL-C, mmol/L (SD) | 1.2 (0.27) | 1.2 (0.27)a |
Mean baseline TG, mmol/L (SD) | 2.0 (1.0) | 2.0 (0.93)a |
ITT: Intention to treat, SD: Standard deviation, BMI: Body mass index, LDL-C: Low-density lipoprotein cholesterol, HDL-C: High-density lipoprotein cholesterol, TG: Triglycerides
an = 232